Alejandro González Veliz: The Future of Cardiogenic Shock Lies in Precision Medicine
Alejandro González Veliz, Interventional Cardiologist at Institute of Cardiology and Cardiovascular Surgery, shared a post on LinkedIn about a recent article by Shashank Shekhar et al., published in Journal of Cardiothoracic and Vascular Anesthesia, adding:
“Cardiogenic shock remains one of the greatest challenges in cardiovascular medicine, with mortality still reaching 30–60% despite advances in reperfusion and mechanical circulatory support.
This updated review highlights a major shift in our approach: moving beyond simply treating hypotension toward recognizing shock early, using structured SCAI staging, invasive hemodynamic assessment, and multidisciplinary shock teams to personalize therapy.
Mechanical circulatory support is not a universal solution – timing, patient selection, and continuous reassessment are what truly determine outcomes.
As our understanding of shock physiology evolves, the future lies in precision medicine: identifying the right patient, selecting the right device, and intervening before irreversible organ injury occurs.
Which aspect of cardiogenic shock management do you think will have the greatest impact over the next decade: earlier diagnosis, invasive hemodynamic monitoring, or newer mechanical circulatory support strategies?”
Title: Cardiogenic Shock: Current Evidence, Guideline Perspectives, and Outcomes
Authors: Shashank Shekhar, Ankit Agrawal, Hussein Almadhoun, Patrick M. Wieruszewski, Gauranga Mahalwar, Tikal Kansara, James A. Nelson, Steven T. Morozowich, Ivan Nunez Gil, Seshasayee Narasimhan, Harish Ramakrishna, Omar Elmadhoun
Other posts featuring Alejandro González Veliz on Hemostasis Today.
-
Nov 8, 2026, 19:31Anna Kajaste-Rudnitski: Presenting AAV-Induced p53 Signalling in Human CNS Cells at ESGCT 26
-
Nov 8, 2026, 19:29David McIntosh: Cybersecurity Matters, but Blood Availability Remains the Bigger Challenge
-
Nov 8, 2026, 19:26Wenxue Ma: An Integrative Framework for Macrophage-Mediated Therapeutic Resistance in Cancer
-
Nov 8, 2026, 19:25Yildiz Yigit: Presenting a Polycythemia Vera Case at the MPN Subcommittee Session
-
Nov 8, 2026, 18:56Denis Oduor: Strengthening the Regulation and Delivery of Blood Transfusion and Transplantation Services
-
Nov 8, 2026, 18:28Raghavendra Rao: A Narrative Review on Chronic Venous Disease during Pregnancy
-
Nov 8, 2026, 17:57Dhiren Patel: PLD1-Derived Phospholipids Regulate NAD Kinase and ROS Production in Neutrophils
-
Nov 8, 2026, 17:48Andra T.: What Causes Antiphospholipid Syndrome? – Four Steps, not One Cause
-
Nov 8, 2026, 17:38Nasrin Samadi: Can a Normal Clotting Test Be Misleading?